SCHEMBL19036447

SCHEMBL19036447

Cc1ccc(/C=N/N=C\N)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.77
▸ SMN1; SMN2 Q16637 2/20 0.77
▸ RAB9A P51151 2/20 0.77
▸ GRIN2D O15399 4/20 0.59
▸ GRIN3B O60391 4/20 0.59
▸ GRIN1 Q05586 4/20 0.59
▸ GRIN2A Q12879 4/20 0.59
▸ GRIN2B Q13224 4/20 0.59
▸ GRIN2C Q14957 4/20 0.59
▸ GRIN3A Q8TCU5 4/20 0.59
▸ ALDH1A1 P00352 4/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RRM1 P23921 1/20 0.44
▸ CASP3 P42574 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ F2 P00734 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2608307 0.88 NPC1 (1.00) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL11743247 0.88 NPC1 (1.00) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL7793321 0.77 NPC1 (0.77) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL7793323 0.77 NPC1 (0.77) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL7793264 0.77 NPC1 (0.68) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL7793269 0.77 NPC1 (0.68) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL10942218 0.76 NPC1 (0.74) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL22995747 0.74 NPC1 (0.71) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL22198250 0.74 NPC1 (0.71) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B
SCHEMBL22198249 0.74 SMN1; SMN2 (0.71) NPC1SMN1; SMN2RAB9AGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
Send feedback